|
Q4 2017
Filed on Feb 14, 2018
|
59,291
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
30,515
|
$43.69 - $53.96
$1.33M - $1.65M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
29,184
|
$31.22 - $36.13
$911K - $1.05M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
30,000
|
$16.21 - $19.23
$486K - $577K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
34,000
|
$69.7 - $77.01
$2.37M - $2.62M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
32,162
|
$73.62 - $85.66
$2.37M - $2.75M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
36,861
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
32,178
|
$16.6 - $20.65
$534K - $664K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
23,661
|
$84.03 - $99.98
$1.99M - $2.37M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
20,436
|
$50.43 - $64.64
$1.03M - $1.32M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
12,479
|
$210.36 - $240.51
$2.63M - $3M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
24,174
|
$3.94 - $6.64
$95.2K - $161K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
291,529
|
N/A
|
|
Five Prime Therapeutics Inc
|
Q4 2017
Filed on Feb 14, 2018
|
50,919
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
78,918
|
$40.45 - $45.07
$3.19M - $3.56M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
104,750
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
40,037
|
$40.95 - $49.65
$1.64M - $1.99M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
147,141
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
39,106
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
38,546
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
27,929
|
$40.47 - $47.58
$1.13M - $1.33M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
170,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
78,332
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
23,512
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
102,000
|
$34.05 - $37.9
$3.47M - $3.87M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
80,000
|
$68.28 - $72.18
$5.46M - $5.77M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
203,325
|
$10.39 - $16.34
$2.11M - $3.32M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
64,973
|
$46.49 - $54.32
$3.02M - $3.53M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
67,500
|
$94.75 - $104.34
$6.4M - $7.04M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
1,000
|
$94.75 - $104.34
$94.8K - $104K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
18,024
|
$48.6 - $60.1
$876K - $1.08M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
80,000
|
$69.46 - $78.39
$5.56M - $6.27M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
7,209
|
$76.25 - $80.34
$550K - $579K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
28,500
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
35,098
|
$13.06 - $19.67
$458K - $690K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
10,814
|
$72.53 - $118.27
$784K - $1.28M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
14,419
|
N/A
|
|
Black Knight Finl Svcs Inc
|
Q3 2017
Filed on Nov 14, 2017
|
7,376
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
22,592
|
$80.6 - $94.95
$1.82M - $2.15M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
7,209
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
7,210
|
$39.62 - $46.17
$286K - $333K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
99,944
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
53,000
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
50,468
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
28,351
|
$18.0 - $22.52
$510K - $638K
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
71,799
|
$18.9 - $28.2
$1.36M - $2.02M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
39,000
|
$69.95 - $85.8
$2.73M - $3.35M
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
120,956
|
$7.55 - $10.05
$913K - $1.22M
|
|
Tetraphase Pharmaceuticals I
|
Q3 2017
Filed on Nov 14, 2017
|
161,403
|
N/A
|
|
|
Q3 2017
Filed on Nov 14, 2017
|
2,500
|
N/A
|
|